Transaction · 0001193125-26-374645

Rahmer Peter

Rahmer Peter, SR, reported an open-market or private sale at Relay Therapeutics, Inc. involving 4508.000000 shares for an estimated $90295.24. Reported holdings after the transaction were 223657.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
RLAYRelay Therapeutics, Inc.
Filing timeAug 28
Trade dateAug 26, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

RLAY price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RLAY since 2026-08-28Filed 7 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-374645
Common Stock
Transaction date
Aug 26, 2026
Filed Aug 28, 2026, 08:43 PM · 2d delay
Shares
4.50k sh
$2.00k per share
Estimated value
-$9.02M
Computed from shares × price
Holdings after
223k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $20.00 to $20.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to p…

  3. F3

    Includes 6,102 shares underlying restricted stock units.

Original filing · 0001193125-26-374645
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RLAY